Clinical Characteristics of 254 COVID-19 Inpatients in Yichang, Hubei, China, and Efficacy of Integrated Chinese and Western Medicine Treatment
Yongxin Yi,1 Jiayang Fang,1 Yunzhu Liu,1 Yidong Gao,1 Weizhi Lin,1 Dongdong Hao,2 Xing Zhang,3,4 Min Zhang1 1Department of Encephalopathy, the Third People’s Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Fuzhou, People’s Republic of China; 2Department of Outpatient, Lanzh...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2022-11-01
|
| Series: | International Journal of General Medicine |
| Subjects: | |
| Online Access: | https://www.dovepress.com/clinical-characteristics-of-254-covid-19-inpatients-in-yichang-hubei-c-peer-reviewed-fulltext-article-IJGM |
| _version_ | 1797988581255413760 |
|---|---|
| author | Yi Y Fang J Liu Y Gao Y Lin W Hao D Zhang X Zhang M |
| author_facet | Yi Y Fang J Liu Y Gao Y Lin W Hao D Zhang X Zhang M |
| author_sort | Yi Y |
| collection | DOAJ |
| description | Yongxin Yi,1 Jiayang Fang,1 Yunzhu Liu,1 Yidong Gao,1 Weizhi Lin,1 Dongdong Hao,2 Xing Zhang,3,4 Min Zhang1 1Department of Encephalopathy, the Third People’s Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Fuzhou, People’s Republic of China; 2Department of Outpatient, Lanzhou 7th Rest Center for Retired Cadre, Gansu Military Region, Lanzhou, People’s Republic of China; 3Department of Medicine, the State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing, People’s Republic of China; 4Department of Medicine, Nanjing Simcere Medical Laboratory Science Co., Ltd, Nanjing, People’s Republic of ChinaCorrespondence: Min Zhang, Department of Encephalopathy, the Third People’s Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Fuzhou, People’s Republic of China, Email minzhang_2018@163.comIntroduction: There is no effective treatment plan for coronavirus disease 2019 (COVID-19). We employed a combination of Chinese and Western medicine treatment for some COVID-19 inpatients.Methods: This study was a prospective cohort study that observed non-critical COVID-19 inpatients. The differences will be observed in the time from admission to two consecutive 2019-nCoV nucleic acid test negatives and the Visual Analog Scale (VAS) score between the two groups.Results: A total of 254 confirmed COVID-19 patients were included in this study. The median time from the admission to two consecutive negative nucleic acid tests was 14 days for the integrated Chinese and Western Medicine (ICWM) group, while the Western Medicine (WM) group was 16 days. Besides, the median VAS score of the ICWM group was 0, which was an average decrease of 2 points compared to the time of admission.Conclusion: For non-critical COVID-19 patients, it was safe and have more benefits to add traditional Chinese medicine decoction based on WM treatment.Keywords: clinical characteristics, COVID-19 inpatients, efficacy, integrated Chinese and Western medicine treatment |
| first_indexed | 2024-04-11T08:05:11Z |
| format | Article |
| id | doaj.art-cc16cb72354240c9ac993f11621343ae |
| institution | Directory Open Access Journal |
| issn | 1178-7074 |
| language | English |
| last_indexed | 2024-04-11T08:05:11Z |
| publishDate | 2022-11-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | International Journal of General Medicine |
| spelling | doaj.art-cc16cb72354240c9ac993f11621343ae2022-12-22T04:35:34ZengDove Medical PressInternational Journal of General Medicine1178-70742022-11-01Volume 158191820079653Clinical Characteristics of 254 COVID-19 Inpatients in Yichang, Hubei, China, and Efficacy of Integrated Chinese and Western Medicine TreatmentYi YFang JLiu YGao YLin WHao DZhang XZhang MYongxin Yi,1 Jiayang Fang,1 Yunzhu Liu,1 Yidong Gao,1 Weizhi Lin,1 Dongdong Hao,2 Xing Zhang,3,4 Min Zhang1 1Department of Encephalopathy, the Third People’s Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Fuzhou, People’s Republic of China; 2Department of Outpatient, Lanzhou 7th Rest Center for Retired Cadre, Gansu Military Region, Lanzhou, People’s Republic of China; 3Department of Medicine, the State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing, People’s Republic of China; 4Department of Medicine, Nanjing Simcere Medical Laboratory Science Co., Ltd, Nanjing, People’s Republic of ChinaCorrespondence: Min Zhang, Department of Encephalopathy, the Third People’s Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Fuzhou, People’s Republic of China, Email minzhang_2018@163.comIntroduction: There is no effective treatment plan for coronavirus disease 2019 (COVID-19). We employed a combination of Chinese and Western medicine treatment for some COVID-19 inpatients.Methods: This study was a prospective cohort study that observed non-critical COVID-19 inpatients. The differences will be observed in the time from admission to two consecutive 2019-nCoV nucleic acid test negatives and the Visual Analog Scale (VAS) score between the two groups.Results: A total of 254 confirmed COVID-19 patients were included in this study. The median time from the admission to two consecutive negative nucleic acid tests was 14 days for the integrated Chinese and Western Medicine (ICWM) group, while the Western Medicine (WM) group was 16 days. Besides, the median VAS score of the ICWM group was 0, which was an average decrease of 2 points compared to the time of admission.Conclusion: For non-critical COVID-19 patients, it was safe and have more benefits to add traditional Chinese medicine decoction based on WM treatment.Keywords: clinical characteristics, COVID-19 inpatients, efficacy, integrated Chinese and Western medicine treatmenthttps://www.dovepress.com/clinical-characteristics-of-254-covid-19-inpatients-in-yichang-hubei-c-peer-reviewed-fulltext-article-IJGMclinical characteristicscovid-19 inpatientsefficacyintegrated chinese and western medicine treatment. |
| spellingShingle | Yi Y Fang J Liu Y Gao Y Lin W Hao D Zhang X Zhang M Clinical Characteristics of 254 COVID-19 Inpatients in Yichang, Hubei, China, and Efficacy of Integrated Chinese and Western Medicine Treatment International Journal of General Medicine clinical characteristics covid-19 inpatients efficacy integrated chinese and western medicine treatment. |
| title | Clinical Characteristics of 254 COVID-19 Inpatients in Yichang, Hubei, China, and Efficacy of Integrated Chinese and Western Medicine Treatment |
| title_full | Clinical Characteristics of 254 COVID-19 Inpatients in Yichang, Hubei, China, and Efficacy of Integrated Chinese and Western Medicine Treatment |
| title_fullStr | Clinical Characteristics of 254 COVID-19 Inpatients in Yichang, Hubei, China, and Efficacy of Integrated Chinese and Western Medicine Treatment |
| title_full_unstemmed | Clinical Characteristics of 254 COVID-19 Inpatients in Yichang, Hubei, China, and Efficacy of Integrated Chinese and Western Medicine Treatment |
| title_short | Clinical Characteristics of 254 COVID-19 Inpatients in Yichang, Hubei, China, and Efficacy of Integrated Chinese and Western Medicine Treatment |
| title_sort | clinical characteristics of 254 covid 19 inpatients in yichang hubei china and efficacy of integrated chinese and western medicine treatment |
| topic | clinical characteristics covid-19 inpatients efficacy integrated chinese and western medicine treatment. |
| url | https://www.dovepress.com/clinical-characteristics-of-254-covid-19-inpatients-in-yichang-hubei-c-peer-reviewed-fulltext-article-IJGM |
| work_keys_str_mv | AT yiy clinicalcharacteristicsof254covid19inpatientsinyichanghubeichinaandefficacyofintegratedchineseandwesternmedicinetreatment AT fangj clinicalcharacteristicsof254covid19inpatientsinyichanghubeichinaandefficacyofintegratedchineseandwesternmedicinetreatment AT liuy clinicalcharacteristicsof254covid19inpatientsinyichanghubeichinaandefficacyofintegratedchineseandwesternmedicinetreatment AT gaoy clinicalcharacteristicsof254covid19inpatientsinyichanghubeichinaandefficacyofintegratedchineseandwesternmedicinetreatment AT linw clinicalcharacteristicsof254covid19inpatientsinyichanghubeichinaandefficacyofintegratedchineseandwesternmedicinetreatment AT haod clinicalcharacteristicsof254covid19inpatientsinyichanghubeichinaandefficacyofintegratedchineseandwesternmedicinetreatment AT zhangx clinicalcharacteristicsof254covid19inpatientsinyichanghubeichinaandefficacyofintegratedchineseandwesternmedicinetreatment AT zhangm clinicalcharacteristicsof254covid19inpatientsinyichanghubeichinaandefficacyofintegratedchineseandwesternmedicinetreatment |